Holen Sie sich die Stockscreener-App
0.33
4.30%
0.0136
Finanzdaten der Virpax Pharmaceuticals Inc-Aktie (VRPX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
29.50%
3.3025
|
4.6841 | 6.1151 | 3.2395 | 1.6511 |
| Operating Income/Loss |
29.50%
-3.3025
|
-4.6841 | -6.1151 | -3.2395 | -1.6511 |
| Nonoperating Income/Loss |
0.082
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
29.40%
-3.2204
|
-4.5617 | -5.9945 | -3.1128 | -1.5205 |
| Income/Loss From Continuing Operations After Tax |
29.40%
-3.2204
|
-4.5617 | -5.9945 | -3.1128 | -1.5205 |
|
Net Income/Loss
|
29.40%
-3.2204
|
-4.5617 | -5.9945 | -3.1128 | -1.5205 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
111.11%
1.1712
|
-10.54 | 11.71 | 11.71 | 11.71 |
| Diluted Average Shares |
111.11%
1.1712
|
-10.54 | 11.71 | 11.71 | 11.71 |
| Basic Earnings Per Share |
77.20%
-2.75
|
-12.06 | -0.51 | -0.27 | -0.13 |
| Diluted Earnings Per Share |
77.20%
-2.75
|
-12.06 | -0.51 | -0.27 | -0.13 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):